Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.

Keywords

Myeloid leukemia, Myeloid, Cancer research, Biology, Mutation

References

• N‐ras and p53 gene mutations in Japanese patients with myeloproliferative disordersShigeharu Tsurumi, Yuichi Nakamura, Kazuhiro Maki — 2002
• Gata2 is required for HSC generation and survivalEmma de Pater, Polynikis Kaimakis, Chris S. Vink — 2013
• Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe Cancer Genome Atlas Research Network — 2013
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesKristian Cibulskis, Michael S. Lawrence, Scott L. Carter — 2013
• Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding proteinArchibald S. Perkins, Richard Fishel, N.A. Jenkins — 1991
• GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutationsClaire L. Green, Kiran Tawana, Robert K. Hills — 2013
• Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis.Neil P. Rodrigues — 2005
• A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expressionHiromi Yamazaki, Mikiko Suzuki, Akihito Otsuki — 2014
• A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.Stefan Gröschel, Mathijs A. Sanders, Remco M. Hoogenboezem — 2014
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataKai Wang, Man Li, Håkon Håkonarson — 2010
• Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.Amy P. Hsu, Elizabeth P. Sampaio, Javed Khan — 2011
• Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid LeukemiaChristopher N Hahn, Chan‐Eng Chong, Catherine Carmichael — 2011
• Genomic Dark Matter Sheds Light on EVI1-driven LeukemiaRichard P. Koche, Scott A. Armstrong — 2014
• GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome.Amy P. Hsu, Kirby D. Johnson, Emilia Liana Falcone — 2013
• AML1 mutations induced MDS and MDS/AML in a mouse BMT model.Naoko Watanabe‐Okochi, Jiro Kitaura, Ryoichi Ono — 2008
• GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.Philipp A. Greif, Annika Dufour, Nikola P. Konstandin — 2012
• Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D. McLellan, Fabio Vandin — 2013
• Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid LeukemiaBertil Johansson, Thoas Fioretos, Felix Mitelman — 2002
• TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.Frank G. Rücker, Richard F. Schlenk, Lars Bullinger — 2012
• Cooperating gene mutations in acute myeloid leukemia: a review of the literatureAline Renneville, Christophe Roumier, Valéria Biggio — 2008

Cited by

• Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.Wei Wang, Jörge E. Cortes, Pei Lin — 2015
• 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.Marc De Braekeleer, Marie‐Josée Le Bris, Étienne De Braekeleer — 2015
• ACUTE LEUKEMIAS XVBruno Bockorny, Constantin A Dasanu — 2015
• Genes break barrier between MDS and AML.Claudia Haferlach — 2015
• ST2: the biomarker at the heart of GVHD severity.Sawa Ito, A. John Barrett — 2015
• Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Tapan M. Kadia, Farhad Ravandi, Jörge E. Cortes — 2015
• Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrumEric Wong, Surender Juneja — 2015
• T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesRaynier Devillier, Stéfania Bramanti, Sabine Fürst — 2016
• Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.David Grimwade, Adam Ivey, Brian J.P. Huntly — 2016
• Review: Aberrant EVI1 expression in acute myeloid leukaemiaAdil Al Hinai, Peter J.M. Valk — 2016
• Comprehensive mutational profiling of core binding factor acute myeloid leukemia.Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel — 2016
• Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CRXing‐Xiang He, Qianqian Wang, Jiepeng Cen — 2016
• Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger — 2016
• Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemiaSheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung — 2016
• Rigosertib in myelodysplastic syndromes (MDS)Azra Raza, Abdullah Mahmood Ali, M. V. Ramana Reddy — 2016
• The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).Huan‐You Wang, Hooman H. Rashidi — 2016
• Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemiasBrittany Knick Ragon, Hagop M. Kantarjian, Elias Jabbour — 2016
• Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormalityAnn‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek — 2016
• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Hartmut Döhner, Elihu H. Estey, David Grimwade — 2017
• Quality Assurance Guided FISH-Analysis for Optimal Detection of AMLAssociated Chromosomal AberrationsDina Fouad — 2017

Related papers

• Epigenetic Modifiers as Game Changers for Healthy AgingShikha Sharma, Ramesh Bhonde — 2023
• Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental DisordersTakeo Kubota, Takae Hirasawa, Kunio Miyake — 2012
• INHERITANCE OF ACQUIRED EPIGENETIC MODIFICATIONS AND ITS ROLE IN DISEASE SUSCEPTIBILITYGülsüm Kayman Kürekçi, Merve Bunsuz, Gizem Önal — 2017
• [Advances in the mouse models of myeloid leukemia].Chen-Tao Ge, Caiyun Fu — 2019
• Regulation of c‐fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia‐MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1Eun Sook Hwang, Jeong-Ho Hong, Suk Chul Bae — 1999
• EFFECTS OF LONG-TERM COMBINED CHEMOTHERAPY ON SISTER CHROMATID EXCHANGE IN THE PATIENTS WITH ADULT LEUKEMIAYing Liang — 2001